CIK: 1337801 - Address: C/O Bridgebio Pharma, Inc., 3160 Porter Dr., Suite 250, Palo Alto, CA 94304
5 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/5/24 16:53
6/3/24
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsScott Randal W.CADS.m-7630.320-3-229I
3/5/24 16:00
3/1/24
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsScott Randal W.CADS-8534.000-3-1812I
12/20/23 16:00
12/18/23
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsScott Randal W.CADS-8040.000-2-1314I
12/5/23 16:00
12/1/23
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsScott Randal W.CADS-7429.400-3-1416I
9/7/23 16:00
9/5/23
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsScott Randal W.CADS-7530.000-3-1219I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact